Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice

European Respiratory Journal

Volumn 38, Issue 2, 2011, Pages 415-424

  Kishi, J ^a   Nishioka, Y ^a   Kuwahara, T ^a   Kakiuchi, S ^a   Azuma, M ^a   Aono, Y ^a   Makino, H ^a   Kinoshita, K ^a   Kishi, M ^a   Batmunkh, R ^a   Uehara, H ^a   Izumi, K ^a   Sone, S ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CCR5; CXCR3; Propionibacterium acnes; Pulmonary granulomatosis; Th1 chemokines

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; COMPLEMENTARY DNA; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCL4 GENE; CCR5 GENE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CXCL10 GENE; CXCL9 GENE; CXCR3 GENE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; LUNG GRANULOMATOSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RECEPTOR BLOCKING; TH1 CELL; TREATMENT OUTCOME; UPREGULATION;

AMIDES; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL4; CHEMOKINE CXCL10; CHEMOKINE CXCL9; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GRANULOMA; INTERFERON-GAMMA; LUNG DISEASES; MICE; MICE, INBRED C57BL; PROPIONIBACTERIUM ACNES; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR3; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051520852     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00070610     Document Type: Article

References (33)

1. American Thoracic Society, European Respiratory Society, World Association of Sarcoidosis and Other Granulomatous Disorders. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-755.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-2165.
3. Paramothayan S, Lasserson T. Treatment for pulmonary sarcoidosis. Respir Med 2008; 102: 1-9.
4. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005; 60: 565-582. (Pubitemid 40562463)
5. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-134. (Pubitemid 28044828)
6. + lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 2001; 163: 115-121.
7. Prasse A, Georges CG, Biller H, et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000; 122: 241-248.
8. Bergeron A, Bonay M, Kambouchner M, et al. Cytokine patterns in tuberculous and sarcoid granulomas; correlation with histopathologic features of the granulomatous response. J Immunol 1997; 159: 3034-3043. (Pubitemid 127681328)
9. Nishioka Y, Manabe K, Kishi J, et al. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages. Clin Exp Immunol 2007; 149: 317-326. (Pubitemid 47063058)
10. Agostini C, Cassatella M, Zambello R, et al. Involvement of the IP- 10 chemokine in sarcoid granulomatous reactions. J Immunol 1998; 161: 6413-6420. (Pubitemid 28536019)
11. Katchar K, Eklund A, Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 2003; 254: 564-571. (Pubitemid 37521853)
12. H2-mediated lung disease. J Allergy Clin Immunol 2001; 107: 664-670.
13. Capelli A, di Stefano A, Lusuards M, et al. Increased macrophage inflammatory protein-1α and macrophage inflammatory protein-1βlevels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis. Am J Respir Crit Care Med 2002; 165: 236-241. (Pubitemid 34084464)
14. Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, et al. Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol 2006; 25: 596-597. (Pubitemid 44137652)
15. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174: 795-802. (Pubitemid 44511661)
16. Homma JY, Abe C, Chosa H, et al. Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med 1978; 48: 251-255. (Pubitemid 9013113)
17. Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999; 354: 120-123. (Pubitemid 29313147)
18. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002; 40: 198-204. (Pubitemid 34027624)
19. Nishioka Y, Yano S, Fujiki F, et al. Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance. Int J Cancer 1997; 71: 170-177. (Pubitemid 27252986)
20. Baba M, Nishimura O, Kanzaki N, et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA 1999; 96: 5698-5703.
21. Gao P, Zhou X-Y, Yashiro-Ohtani Y, et al. The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3. J Leukoc Biol 2002; 73: 273-280.
22. Nishioka Y, Hirao M, Robbins PD, et al. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to constitutively express interleukin-12. Cancer Res 1999; 59: 4035-4041. (Pubitemid 29393574)
23. Aono Y, Nishioka Y, Inayama Y, et al. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 2005; 171: 1279-1285. (Pubitemid 40740736)
24. Kishuku M, Nishioka Y, Abe S, et al. Expression of soluble vascular endothelial growth factor receptor-1 in human monocyte-derived mature dendritic cells contributes to their antiangiogenic property. J Immunol 2009; 183: 8176-8185.
25. Hashida N, Ohguro N, Nakai K, et al. Microarray analysis of cytokine and chemokine gene expression after predonisolone treatment in murine experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 2005; 46: 4224-4234. (Pubitemid 44264626)
26. Nishiwaki T, Yoneyama H, Eishi Y, et al. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 2004; 165: 631-639. (Pubitemid 38971392)
27. Ichiyasu H, Suga M, Matsukawa A, et al. Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits. J Leukoc Biol 1999; 65: 482-491. (Pubitemid 29160176)
28. McCaskill JG, Chason KD, Hua X, et al. Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice. Am J Repir Cell Mol Biol 2006; 35: 347-356. (Pubitemid 44353403)
29. Iyonaga K, McCarthy KM, Schneeberger EE. Dendritic cells and the regulation of a granulomatous immune response in the lung. Am J Respir Cell Med Biol 2002; 26: 671-679. (Pubitemid 34557367)
30. Katchar K, Eklund A, Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 2003; 254: 564-571. (Pubitemid 37521853)
31. Hartl D, Krauss-Etschmann S, Koller B, et al. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung disease. J Immunol 2008; 181: 8053-8067.
32. Reichel CA, Khandoga A, Anders H-J, et al. Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue. J Leukoc Biol 2006; 79: 114-122. (Pubitemid 43054256)
33. Samokhin AO, Bühling F, Theissig F, et al. ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis. Am J Pathol 2010; 176: 1148-1156.